Live Earnings Conference Call: BR Biopharma's Q3 2026 earnings call is happening now. NASDAQ:BRBI BR Biopharma Q3 2026 Earnings Results & Report $7.08 -0.18 (-2.41%) As of 01:28 PM Eastern This is a fair market value price provided by Massive. Learn more. BR Biopharma reported Q3 2026 earnings on November 3, 2026. The company reported EPS of $0.05, while revenue was $23.80 million. Research:ProfileEarnings HistoryForecast Earnings Announcement Details QuarterQ3 2026Report DateNovember 3, 2026TimeAfter Market ClosesConference Call DateNovember 6, 2026Conference Call1:00 PM ET Live Call not available Live EventEarnings Conference CallBR Biopharma Q3 202600:00 / 00:00Live Transcript Follow Audio BR Biopharma EPS ResultsActual EPS$0.05Consensus EPS N/ABeat/MissN/AOne Year Ago EPSN/ABR Biopharma Revenue ResultsActual Revenue$23.80 millionExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/AConference Call ResourcesSlide DeckPress ReleaseEarnings HistoryCompany ProfileSlide DeckFull Screen Slide DeckPowered by Earnings DocumentsPress Release BR Biopharma Q3 2026 Earnings FAQ Did BR Biopharma beat earnings estimates for Q3 2026? BR Biopharma (NASDAQ:BRBI) reported earnings of $0.05 per share for Q3 2026. The report was announced on Tuesday, November 3, 2026. What was BR Biopharma's revenue for Q3 2026? BR Biopharma reported revenue of $23.80 million for Q3 2026. BR Biopharma Earnings HeadlinesBR Biopharma (NASDAQ:BRBI) Stock Rating Lowered by CitigroupOctober 29, 2026 | americanbankingnews.comSee More BR Biopharma Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like BR Biopharma? Sign up for Earnings360's daily newsletter to receive timely earnings updates on BR Biopharma and other key companies, straight to your email. Email Address About BR BiopharmaBRBI BR Partners S.A., through its subsidiaries, operates as an investment bank which specializes in providing financial services for entrepreneurs and families principally in Brazil. It offers financial advisory services for mergers and acquisitions, capital markets, board services, shareholders, special situations and restructuring, pre-IPO, and privatization; and wealth management services. BRBI BR Partners S.A. is based in S?o Paulo, Brazil.View BR Biopharma ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles CVS Raised Its Outlook and Announced a Breakup—So Why Did the Stock Drop?Array and Shoals Are Merging: Who Really Wins the All-Stock Solar Deal?Riot's $28B Lease Shows Why Location and Contracts Matter in AICould the Midterms Revive Medicare for All? 3 Healthcare Stocks to WatchDuolingo's User Growth Is Outpacing Bookings, But Is Its Strategy Paying Off?Qualcomm Beat Earnings, But Its Fastest-Growing Businesses Have a CatchPowering Up: Freeport-McMoRan's $4.5B Copper Expansion Upcoming Earnings Occidental Petroleum (11/9/2026)KKR & Co. Inc. (11/9/2026)Barrick Mining (11/9/2026)Constellation Energy (11/9/2026)Petroleo Brasileiro S.A.- Petrobras (11/10/2026)Transdigm Group (11/10/2026)Honda Motor (11/11/2026)Brookfield (11/12/2026)NU (11/12/2026)Applied Materials (11/12/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
